NanoViricides President Applauds FDA's COVID-19 Booster Shot Policy, Emphasizes Need for Alternatives
NanoViricides President Dr. Anil Diwan praises FDA's COVID-19 booster shot policy, emphasizes need for alternatives like antiviral NV-387. Learn more about NanoViricides' nanomaterials for antiviral therapy.
This news matters as it showcases the importance of evidence-based guidance in COVID-19 management. The shift in booster shot recommendations impacts high-risk groups and highlights the potential of alternative antiviral solutions like NV-387.
